These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36091162)

  • 1. DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma.
    Song D; Zhou Z; Wu J; Wei T; Zhao G; Ren H; Zhang B
    Front Oncol; 2022; 12():877817. PubMed ID: 36091162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
    Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
    Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer.
    Yuan S; Gao Y; Xia Y; Wang Z; Wang X
    Front Genet; 2022; 13():1008644. PubMed ID: 36276973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma.
    Yin T; Zhao L; Yao S
    BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of m
    Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
    Front Immunol; 2021; 12():782551. PubMed ID: 34975871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma.
    Shi R; Zhao H; Zhao S; Yuan H
    Aging (Albany NY); 2022 Jun; 14(12):5271-5291. PubMed ID: 35771147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
    Li R; Zhao W; Liang R; Jin C; Xiong H
    Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
    [No Abstract]   [Full Text] [Related]  

  • 10. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
    Zhao M; Shen S; Xue C
    Front Immunol; 2022; 13():805967. PubMed ID: 35401564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
    Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S
    Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma.
    Shen B; Wen Z; Lv G; Wang J; Han R; Jiang J
    Front Genet; 2022; 13():1022078. PubMed ID: 36299585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma.
    Xing J; Shen S; Dong Z; Hu X; Xu L; Liu X; Li Q; Zhang Y; Cui G; Yu Z
    Front Cell Dev Biol; 2021; 9():761391. PubMed ID: 34858985
    [No Abstract]   [Full Text] [Related]  

  • 14. An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
    Du Y; Ma Y; Zhu Q; Liu T; Jiao Y; Yuan P; Wang X
    Front Pharmacol; 2021; 12():707930. PubMed ID: 34248650
    [No Abstract]   [Full Text] [Related]  

  • 15. Uncovering the Association Between m
    Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
    Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
    [No Abstract]   [Full Text] [Related]  

  • 16. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer.
    Lu S; Hua J; Liu J; Wei M; Liang C; Meng Q; Zhang B; Yu X; Wang W; Xu J
    BMC Cancer; 2022 Jul; 22(1):804. PubMed ID: 35864471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hub ten gene-based risk score system using RNA m
    Yuan B; Liu W; Huo M; Zhang J; Yang Y; Gao T; Yin X; Yang T; Teng X; Huang W; Yu H
    Breast Cancer; 2022 Jul; 29(4):645-658. PubMed ID: 35174450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer.
    Zhu H; Jia X; Wang Y; Song Z; Wang N; Yang Y; Shi X
    Front Oncol; 2021; 11():714267. PubMed ID: 34604051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.